Trial NCT04298918

View at ClinicalTrials.gov 
Org. Study IDs: CO41863
Secondary IDs: 2019-004200-35

Last trial update was posted on 2021-11-08

MeSH Interventions

Ado-Trastuzumab Emtansine Maytansine Trastuzumab Venetoclax

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

Decision to discontinue the study based on broader development and strategic prioritisation. The Sponsor concludes there is no benefit-risk impact on the CO41863 study.

Limitations And Caveats

The study was terminated by the Sponsor. Only 1 participant was enrolled in this study. Based on the low enrolment number, no data is reported here in order to protect and maintain participant privacy/confidentiality.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID